GSK620
GSK620 is a highly selective pan-BD2 BET inhibitor demonstrating potent anti-inflammatory activity in human whole blood assays. Its excellent selectivity profile and favorable oral pharmacokinetics support its use for in vivo research into inflammation and oncology, where BET bromodomain function is implicated.
Product Specifications
CAS Number
2088410-46-0
Product Name Alternative
Anti-inflammatory, blood, human, GSK 620, GSK620, GSK-620, EpigeneticReaderDomain, Epigenetic Reader Domain, oral, pan-BD2, inhibit, Inhibitor, phenotype, whole, selectivity
Field of Research
Epigenetics & Chromatin
Purity
99.05% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:3.3 mg/mL (10.14 mM) ; DMSO:45 mg/mL (138.31 mM)
Smiles
CNC (=O) c1cc (cn (Cc2ccccc2) c1=O) C (=O) NC1CC1
Molecular Formula
C18H19N3O3
Molecular Weight
325.36
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
K1918906 1.0 µg DNA
RPL18AP16 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 1)
Sign In for Pricing
View Details 
